[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]               
[Page 391]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-79]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Importer of Controlled Substances; Notice of Registration

    Notice dated July 28, 2004 and published in the Federal Register on 
August 10, 2004, (69 FR 48522), Hospira, Inc., 1776 North Centennial 
Drive, McPherson, Kansas 67460-1247, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Remifentanil (9739), a basic class of controlled substance listed in 
Schedule II.
    The company plans to import the listed controlled substance for use 
in dosage unit manufacturing.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Hospira, Inc. to import the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Hospira, Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic class 
of controlled substance listed.

    Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 05-60 Filed 1-3-05; 8:45 am]

BILLING CODE 4410-09-P